← Surfer · Sage hub

Sage — The Metabolic Hypothesis of Thyroid Dysfunction

Not medical advice. Informational purposes only. Physiology interpreted through a metabolic lens for metabolically curious adults, with qualified physician interpretation of any personal data. n=1 tracking is not a protocol.

The thermal side of the same axis — heat as the price of flux, the 24-hour temperature curve, the sleeping thermal nest, heat and cold hormesis, fever, the Reye pitfall, malignant hyperthermia and the temperature dashboard — is on Sage — Circadian Temperature.

For the scheduling frame of the same 24-hour thermal wave — Active Phase heat versus Restore Phase nocturnal decline — see the Circadian pillar: Sage — Energy Phase (Circadian). Temperature is a dashboard of engines; Energy Phase is how those engines are timed.

Thyroid Labs as Dashboard Readings of Inadequate Metabolic Persistence

Not medical advice. This is a hypothesis essay grounded in mechanistic evidence, clinical observation, and first-principles reasoning from the metabolic philosophy of medicine. Thyroid disorders require individualized medical evaluation and management. Levothyroxine and other replacement therapies have established indications, particularly in overt primary failure, but are here contextualized within a broader engine-centric framework. Any changes to treatment must be supervised by a qualified physician familiar with the patient's full clinical picture. Prolonged fasting and other intensive interventions carry risks and are appropriate only for carefully selected patients under medical supervision.

In the prevailing paradigm of clinical endocrinology, thyroid dysfunction is framed primarily as a disorder of the thyroid gland itself. Hashimoto's thyroiditis, iodine deficiency, nodular disease, or post-surgical or post-ablative states lead to insufficient production of thyroxine (T4) and its active metabolite triiodothyronine (T3). Diagnosis leans heavily on the TSH-centric model: elevated TSH with low or low-normal FT4 defines overt or subclinical hypothyroidism; levothyroxine is titrated until TSH normalizes within the reference range. Symptoms—fatigue, weight gain, cold intolerance, constipation, dry skin, cognitive slowing, menstrual irregularity—are attributed to insufficient circulating thyroid hormone action, and therapeutic success is declared when the dashboard of serum values improves and the patient reports feeling better.

This model is not without utility. Patients with true glandular destruction or absence benefit from physiologic replacement. The TSH assay is sensitive, and the therapy is inexpensive and generally well-tolerated. Yet the paradigm shares a structural limitation visible across much of contemporary chronic-disease medicine: it excels at describing and correcting the dashboard while remaining relatively blind to the state of the engine. The thyroid axis is not an autonomous endocrine module. It is a high-resolution sensor and effector embedded within the organism's integrated bioenergetic economy. When that economy cannot sustain the conditions for coherent persistence, the thyroid panel becomes a downstream readout of deeper insufficiency rather than the primary locus of disease.

The metabolic hypothesis of thyroid dysfunction proposes that many presentations labeled "hypothyroidism" (and some patterns of "subclinical" disease or treatment-resistant symptoms) are better understood as manifestations of inadequate metabolic persistence rooted in mitochondrial network dysfunction, holobiont compromise, membrane and redox injury, and the resultant failure of the organism to maintain the high-flux energetic state required for full expression of its regulatory and anabolic capacities. Thyroid labs, in this view, are not the disease; they are the canary in the coal mine of systemic bioenergetic coherence.

The Thyroid Axis as Both Regulator and Sensor

Thyroid hormones exert permissive and stimulatory effects on nearly every tissue. They increase basal metabolic rate, enhance mitochondrial biogenesis via PGC-1α, promote thermogenesis in brown and beige fat, facilitate hepatic gluconeogenesis and lipid metabolism, support cardiac output and vascular tone, and are essential for normal brain development and adult cognitive function. T3 binds nuclear receptors that directly influence the transcription of hundreds of genes, including those governing oxidative phosphorylation and uncoupling proteins.

Yet the axis is itself under continuous surveillance by the organism's energy status. The hypothalamus integrates leptin (reflecting adipose energy stores), insulin, and direct cellular energy sensors (AMPK, mTOR) to modulate TRH and subsequently TSH. Peripheral deiodinases—selenoproteins whose activity depends on selenium availability, redox tone, and cellular ATP charge—determine the proportion of T4 converted to active T3 versus inactive reverse T3 (rT3). In states of genuine energy deficit or high oxidative burden, the system adaptively down-regulates: hepatic and renal Type 1 deiodinase activity falls, Type 3 (inactivating) activity rises, T3 declines, rT3 rises, and metabolic rate is throttled to match available capacity. This is the physiologic logic behind the low-T3 state of critical illness and starvation; it is widely regarded as an evolved response, not an error.

When the mitochondrial engine across multiple tissues cannot efficiently generate ATP or contain ROS leak—whether from mtDNA variants, nuclear-encoded OXPHOS defects, peroxidative damage to cardiolipin and inner-membrane lipids, fragmented networks with inadequate mitophagy, or substrate inflexibility—the organism registers a systemic energy constraint. On this hypothesis, the thyroid axis, finely tuned to such signals, reflects this constraint on the dashboard. What the clinician sees as "elevated TSH" or "low T3" may therefore represent either (a) a compensatory attempt to conserve resources or (b) the direct consequence of insufficient bioenergetic power to sustain glandular synthesis, peripheral conversion, or hormone action at target tissues. In either case, on this hypothesis, the root is often not isolated thyroid pathology but compromised metabolic persistence.

Evidence That Metabolic State Drives Thyroid Readouts

Several lines of observation are consistent with the upstream metabolic framing.

Overnutrition itself can induce thyroid dysfunction. In diet-induced obesity models, mice develop hypothyroidism within weeks, with reduced thyroidal thyroglobulin and hormone content, ER stress in thyrocytes, and impaired T4-to-T3 conversion—despite glandular hypertrophy and vascular expansion as attempted compensation. Weight loss reverses the picture. This suggests, at least in mice, that caloric excess and the metabolic inflexibility it induces can directly impair the thyroid axis, not merely coexist with it.

In humans, metabolic syndrome, insulin resistance, and non-alcoholic fatty liver disease are associated with higher TSH independent of overt autoimmunity, though in one large cohort of people with normal thyroid function, a higher FT3/FT4 ratio tracked metabolic syndrome and insulin resistance. The "euthyroid sick syndrome" or non-thyroidal illness syndrome seen in critical care, heart failure, and chronic inflammatory states is now widely interpreted as an adaptive downregulation rather than a target for routine replacement. Even in voluntary caloric restriction or well-formulated low-carbohydrate/ketogenic diets, T3 frequently declines without clinical hypothyroidism or reduction in measured energy expenditure beyond the expected; the change may reflect lowered energy throughput and, in some cases, improved tissue sensitivity rather than pathology.

Autoimmune thyroiditis remains a genuine entity with measurable anti-TPO and anti-Tg antibodies and progressive glandular destruction. Yet even here the metabolic lens adds explanatory power. Chronic low-grade inflammation from metabolic endotoxemia (gut-derived LPS), molecular mimicry between microbial or dietary antigens and thyroid proteins, and impaired regulatory T-cell function secondary to mitochondrial and redox dysregulation may potentiate or accelerate the autoimmune process. On this hypothesis, the holobiont breach does not replace autoimmunity; it supplies the ecologic and immunometabolic conditions in which autoimmunity more readily expresses itself.

Mechanisms: How Inadequate Persistence Produces Thyroid Dashboard Changes

The translation from mitochondrial and systemic bioenergetic failure to altered thyroid parameters occurs through several interlocking channels.

Central sensing. Hypothalamic neurons monitor whole-body energy availability. When mitochondrial ATP production falters across tissues, AMPK activation and leptin resistance (common in insulin-resistant states) may reduce TRH drive. TSH pulse frequency and amplitude decline or the set-point shifts. The thyroid slows because the integrating center has received the message that the organism lacks the energetic surplus to support a higher metabolic rate.

Peripheral conversion. Deiodinase activity is redox- and energy-sensitive. Elevated ROS or depleted glutathione—hallmarks of mitochondrial inefficiency—are proposed to favor the inactivating pathway (rT3 production). Selenium, required for all deiodinases as selenocysteine, may be functionally unavailable even when intake is adequate if gut absorption is compromised or if systemic inflammation upregulates acute-phase sequestration. The result is a circulating profile of low T3 and high rT3 that accurately reflects cellular conditions hostile to thyroid hormone action.

Glandular bioenergetics. Thyroid follicular cells are themselves high-energy consumers. Iodide trapping via NIS, organification by TPO, and hormone packaging require robust OXPHOS and antioxidant defense. Mitochondrial dysfunction within the gland—whether from systemic insults or local inflammatory ROS—may directly impair synthetic capacity before frank autoimmune destruction occurs. The recent demonstration of ER stress and biosynthetic failure in overfed mouse thyroids illustrates this local energetic bottleneck.

Holobiont interface. The gut microbiota is the primary ongoing symbiont mediating energy extraction and micronutrient provisioning. Loss of microbial diversity and function (the "mass extinction event" documented in Western populations) reduces short-chain fatty acid production that supports both colonocyte and systemic energetics, increases intestinal permeability and metabolic endotoxemia, and diminishes the bioavailability of selenium, zinc, and other cofactors. The thyroid axis, dependent on these inputs and vulnerable to the inflammatory milieu they generate, registers the compromise.

Membrane and cristae integrity. Modern dietary patterns rich in industrially processed seed oils deliver high loads of peroxidizable polyunsaturated fatty acids that incorporate into mitochondrial and plasma membranes. On this hypothesis, lipid peroxidation stiffens cristae, increases electron leak and ROS, and impairs the supercomplex organization required for efficient OXPHOS. Thyroid hormone signaling and mitochondrial biogenesis normally reinforce each other; when membrane damage breaks this loop, both the signal and the response suffer. The organism experiences a self-amplifying state of low metabolic persistence whose most visible endocrine signature may be on the thyroid panel.

Taken together, these mechanisms may explain why "normalizing" TSH with exogenous T4 frequently improves some symptoms yet leaves others untouched, and why a subset of patients require escalating doses or never feel fully well despite "optimal" labs. The replacement addresses the downstream readout but does not restore the upstream capacity of the engine to generate and utilize the hormonal signal.

Why the Conventional Paradigm Is Structurally Limited

The TSH-T4 titration model assumes that the primary defect lies in glandular production or that supplying the missing hormone will fully restore downstream physiology. Both assumptions are incomplete when the defect is systemic bioenergetic insufficiency.

First, exogenous T4 does not guarantee adequate T3 generation or action if deiodinases are redox-inhibited or if target cells lack the ATP and mitochondrial infrastructure to respond. Second, chronic suppression of TSH by replacement removes a physiologic sensor that may still be providing useful (if uncomfortable) information about whole-organism energy status. Third, the model creates a lifelong dependency on pharmaceutical titration rather than exploring whether the axis can recalibrate once the engine is repaired. Fourth, on this view, it aligns with institutional incentives that favor identifiable, billable, lifelong interventions over root-cause restoration that may reduce long-term pharmacotherapy.

None of this implies that replacement should be withheld when clearly indicated. It implies that the clinical question should expand from "What is the TSH and how do we normalize it?" to "Why is the thyroid axis reading this way, and what does that tell us about the state of the patient's metabolic persistence?"

Frugal Restoration of the Engine

The metabolic philosophy of medicine privileges interventions that leverage evolved repair programs over perpetual external overrides. For patients whose thyroid presentation is embedded in broader metabolic dysfunction, the therapeutic priority is restoration of mitochondrial network integrity, holobiont coherence, membrane fidelity, and metabolic flexibility—the conditions under which persistence can again be fully expressed and the thyroid axis can re-emerge as a faithful rather than distressed sensor.

Fuel. Return to foods the human metabolism evolved to handle: ruminant and other animal proteins and fats (providing bioavailable carnitine, creatine, B vitamins, and fat-soluble nutrients that support mitochondrial function), fermented and resistant carbohydrates that feed the holobiont symbiont, and the strict exclusion of industrial seed oils whose peroxidative products are proposed to damage mitochondrial membranes. Carbohydrate quantity and timing are context-dependent; some patients benefit from moderate inclusion to support T3 generation during refeeding or recovery, while others achieve greater metabolic flexibility in sustained nutritional ketosis. The guiding principle is not macronutrient ideology but restoration of efficient substrate utilization and minimal membrane injury.

Circadian alignment. Light exposure, feeding windows, temperature cycling, and sleep timing entrain both the HPT axis and mitochondrial dynamics. Misalignment desynchronizes the entire network. Morning sunlight, consistent sleep, and avoidance of blue light at night are not lifestyle flourishes; through circadian timing, they may act as metabolic interventions with effects on the dashboard the clinician monitors.

Strength. Dynamic resistance training increases metabolic demand in a manner that improves mitochondrial respiratory function and may stimulate mitochondrial biogenesis (via PGC-1α and other pathways), improves insulin sensitivity, and signals upward through the energy-sensing hierarchy that capacity exists. Functional metrics—grip strength, gait speed, ability to carry loads—often improve in parallel with subjective energy and, in some cases, with favorable shifts in thyroid parameters as the engine recovers. Strength is not merely anabolic; it is a declaration to the regulatory systems that the organism can sustain higher flux.

Deep reset. Medically supervised prolonged fasting (typically 5–7 or more days of water-only or rigorously supported electrolyte intake in appropriate candidates) activates coordinated programs of autophagy, mitophagy, and hormonal recalibration that are difficult to achieve with chronic caloric restriction or pharmacotherapy alone. A proteomic study of a 7-day water-only fast found more than a thousand of about 3,000 measured plasma proteins shifting, many of them extracellular-matrix proteins. For suitable patients, such resets may lower defended set-points, improve metabolic flexibility, and allow the thyroid axis to recalibrate in a higher-functioning milieu; this has not been tested in trials of thyroid disease. Refeeding protocols must themselves be metabolically optimized—slow, nutrient-dense, and supportive of the recovering holobiont and mitochondria.

Targeted repletion in context. Iodine, selenium, zinc, magnesium, and iron are required for thyroid synthesis, conversion, and transport. When laboratory or clinical evidence of deficiency exists, repletion is rational. The metabolic view, however, simultaneously asks why absorption or utilization was impaired—low stomach acid from energy deficit, gut inflammation, competitive inhibition by heavy metals or goitrogens—and addresses those upstream factors rather than relying on supplementation indefinitely.

Adjunctive agents such as red/near-infrared light therapy (supporting cytochrome c oxidase and mitochondrial membrane potential) may have roles within a broader bioenergetic strategy. These are not substitutes for the foundational pillars but potential accelerators of engine repair in selected cases.

Monitoring necessarily expands beyond the conventional panel. Symptoms remain primary. Resting energy expenditure (if measurable), morning body temperature trends, strength and functional capacity, continuous metabolic data (glucose variability, heart-rate variability, sleep architecture), and inflammatory or oxidative markers provide a richer picture of whether persistence is recovering. In some patients, serial FT3/rT3 ratios or even dynamic testing (e.g., TRH stimulation if available) offer more insight into peripheral thyroid action than static TSH alone.

Continuity with the Metabolic Philosophy

The mitochondrial-metabolic reframing of cancer locates genomic instability and the hallmarks downstream of an initial cellular energy crisis that selects for compensatory mutations. Excess adiposity is frequently a dashboard compensation for mitochondrial inefficiency and metabolic inflexibility rather than a primary disorder of appetite or willpower; GLP-1 agonism changes the readout without repairing the engine, while medically supervised prolonged fasting with metabolic optimization activates intrinsic repair. The gut microbiota is the primary ongoing symbiont whose health determines energy extraction, immune tone, and inflammatory set-points across the host; its compromise is expressed in diverse chronic conditions, of which thyroid dysregulation is one predictable manifestation. The same upstream logic—bioenergetic insufficiency, holobiont fraying, membrane and redox injury—unifies these apparently disparate domains.

In each case the clinical implication is the same: durable improvement requires restoration of the conditions under which the organism's metabolic persistence can be fully expressed, not merely the pharmacological or surgical suppression of its downstream readouts.

Conclusion: From Dashboard Management to Engine Restoration

Thyroid labs are among the most sensitive and accessible readouts of systemic metabolic state available to the clinician. When they are abnormal, the question worth asking is not only "How do we normalize these numbers?" but "What is the state of the engine whose insufficiency these numbers are announcing?" In many patients the answer points upstream—to mitochondrial network dysfunction, holobiont compromise, dietary membrane injury, circadian desynchrony, and the resultant inability of the organism to sustain the high-flux energetic state required for full persistence.

Replacement therapy remains a valuable bridge for those with true primary failure or during active recovery. But the destination is not perpetual titration of a single hormone. It is the restoration of coherent bioenergetic persistence: the conditions under which mitochondria can again efficiently convert fuel to ATP, contain oxidative signaling, support biogenesis and mitophagy, and allow the thyroid axis—and every other regulatory overlay—to function as faithful sensors and effectors rather than distressed alarms.

This is the frugal path. It leverages the repair programs written into human biology by selection. It addresses root causes rather than managing symptoms indefinitely. And it aligns clinical practice with the deeper recognition that health is not the absence of named diseases on a dashboard but the presence of adequate metabolic persistence—the sustained striving of an organism whose engine is once again equal to the demands of persistence.

In an age of rising polypharmacy and siloed subspecialty care, such upstream thinking is not merely philosophically coherent. It is clinically necessary, biologically parsimonious, and, in the fullest sense, an act of stewardship.

Thyroid as tempo governor

Thyroid hormone is how a mammal sets metabolic RPM and obligatory heat.

T3 increases mitochondrial biogenesis and respiratory-chain components. It increases Na+/K+-ATPase and SERCA cycling---classic ATP-consuming futile cycles whose product is heat. It modulates proton leak. It is permissive for UCP1 and for the sympathetic activation of brown fat. Centrally, it talks to the hypothalamus about set-point, TRH, and outflow to vessels and thermogenic organs.

Cold raises peripheral T3 conversion (D2 in BAT) and sympathetic drive so facultative thermogenesis can compensate for a colder world. Energy deficit, illness, and starvation lower active T3 and raise rT3---type-1 allostasis, conservation, less obligatory heat, less ATP demand. Anticipated demand (cold season, pregnancy, training) can push the other way.

Hypothyroidism is cold intolerance because both obligatory thermogenesis and the capacity for facultative thermogenesis collapse. Mild deficit can be patched by sympathetic tone; severe deficit cannot. Hyperthyroidism is heat intolerance because obligatory heat is excessive and cooling itself costs ATP (cardiac output, sweating).

A single morning TSH is one point on a wave. TSH rises in the late afternoon and evening, peaks in the early night, and is then inhibited by sleep. Stay awake and the nocturnal surge keeps climbing; morning TSH after a sleepless night can look "high" without a new gland failure. Nighttime TSH is also less bioactive than daytime TSH, which is why free T4 does not spike with the surge. Low-normal free T3 with rising rT3 and a "normal" TSH is often a dashboard of energy conservation, not a reason to ignore the engines.

Thyroid is cause and readout. Replace T4 without restoring conversion, receptor action, circadian phase, and mitochondrial readiness, and residual coldness, fatigue, and flat temperature curves persist. The gland was never the whole governor.

How the axis talks: TRH, TSH, T4, T3, TBG, rT3

The temperature wave and the thyroid wave are the same conversation written in two dialects. To read labs without worshipping a single TSH, you have to know who is speaking to whom.

TRH --- the hypothalamic request. Thyrotropin-releasing hormone leaves paraventricular neurons when the brain wants more tempo: cold, low circulating thyroid hormone at the hypothalamus, certain circadian phases. TRH tells the pituitary both how much TSH to make and how to glycosylate it---which is why not all TSH molecules are equally bioactive. We almost never measure TRH in clinic. You infer it from context: cold exposure, starvation, sleep loss, pituitary disease.

TSH --- the pituitary work order. TSH tells the thyroid to take up iodine, make thyroglobulin, couple iodotyrosines, and secrete mostly T4 plus a little T3. The pituitary does not see "how warm the person feels." It sees circulating T4 that it converts locally to T3 via deiodinase type 2 (D2) inside the thyrotroph. That is the first interpretive trap. TSH is a T4-at-the-pituitary sensor with a circadian wrapper and a sleep brake. It is not a tissue-T3 meter and it is not a mitochondrial readiness meter. Low tissue T3 with adequate circulating T4 can leave TSH "normal" while the engines are in conservation.

T4 --- the circulating reservoir. The gland's main product is thyroxine: four iodines, long half-life (on the order of a week), a stable pool. Most T4 is cargo, not the active signal. Peripheral tissues decide what to do with it.

T3 --- the tempo signal. Triiodothyronine is the molecule that binds thyroid receptors and writes the metabolic RPM: mitochondrial biogenesis, ion-pump cycling, uncoupling permissiveness, heart rate, heat. Only a minority of circulating T3 is secreted by the gland. Most is made outside the thyroid by outer-ring deiodination of T4. Free T3 is the unbound fraction that can enter cells. It is the closest routine blood proxy for "is tempo actually on," and it is still only a proxy. Local D2 can make T3 inside BAT, brain, and pituitary that never shows as a big swing in the venous draw.

TBG --- the shipping protein. Thyroxine-binding globulin carries most circulating T4 (transthyretin and albumin carry the rest). Greater than 99% of T4 and T3 is bound. Only the free fraction is biologically available. When TBG rises---pregnancy, oral estrogen, some liver states---total T4 and total T3 rise so the free hormone can stay roughly constant. When TBG falls---androgens, nephrotic loss, severe illness---totals fall. That is why free T4 and free T3 exist as assays, and why totals still matter when you suspect a binding-protein story. Estrogen-driven TBG is not hyperthyroidism. A free-hormone assay that is fooled by binding changes is not a gland failure.

rT3 --- the off-ramp. Reverse T3 is T4 with the other ring deiodinated (inner ring, deiodinase type 3). It is not the active tempo signal. In ordinary physiology it is a clearance intermediate. In starvation, carbohydrate deprivation, and non-thyroidal illness, D1 in liver slows: less T4 becomes T3, and rT3 is cleared more slowly, so serum rT3 rises while T3 falls. That is type-1 allostasis written in iodines---conservation, less obligatory heat, less ATP demand. Conventional endocrine often treats rT3 as a test you should not order. The metabolic reading is narrower: rT3 is useful when you already suspect conservation (low free T3, illness, under-eating, overtraining) and you want to know whether T4 is being parked rather than activated. It is not a license to add T3 by recipe. It is a dashboard of conversion under load.

The three deiodinases are the local governors the blood test cannot fully see:

• D1 (liver, kidney): makes circulating T3 from T4 and clears rT3. Sick, fasting, and some drugs slow it. That is the low-T3 / high-rT3 pattern.

• D2 (brain, pituitary, BAT, muscle): local on-demand T3. Cold and sympathetic drive induce D2 in BAT so facultative heat can run even if serum T3 is not high. The pituitary uses D2 to decide TSH---hence TSH tracks T4 more faithfully than it tracks muscle or liver T3.

• D3 (brain, placenta, sick tissues): the inactivator. T4 to rT3, T3 to T2. Fetal and ill tissue use D3 to keep local tempo down.

Feedback in one circuit: high free hormone at hypothalamus and pituitary lowers TRH and TSH. Low free hormone raises them. Sleep inhibits the nocturnal TSH surge. Cold and the clock raise the request. Cytokines, cortisol, and low carbohydrate availability push D1 down and D3 up. hCG in early pregnancy stimulates the TSH receptor and can suppress TSH while raising output. The axis is not a single thermostat. It is a conversation among a request (TRH), a work order (TSH), a reservoir (T4), a tempo signal (T3), a shipping protein (TBG), and an off-ramp (rT3), edited in each organ by deiodinases.

When and how to interpret the draw. Not medical advice. Patterns, not prescriptions. Same clock time, same conditions, interpreted with last night's sleep and last week's load.

• Draw in the morning, fasted if you also want glucose and insulin, before biotin (which wrecks some immunoassays), and---if you take thyroid hormone---usually before that day's dose so you are not sampling a T3 spike or an acutely suppressed TSH.

• TSH alone is a screening work-order, not a complete sentence. Pair it with free T4 at minimum. Add free T3 when symptoms and temperature curve disagree with TSH. Add rT3 when you are asking about conservation versus gland failure. Add TPO and thyroglobulin antibodies when autoimmunity would change the story. Total T4/T3 when pregnancy, estrogen, or a binding-protein puzzle is on the table.

• High TSH + low free T4: primary gland failure until proven otherwise. The work order is loud because the reservoir is empty.

• High TSH + normal free T4: the textbook "subclinical" pattern. It may be early gland failure, recovery from illness, or a set-point the pituitary is defending. Read the temperature curve and symptoms before you treat a number.

• Low or normal TSH + low free T4: look central (pituitary/hypothalamus) or severe non-thyroidal illness---not garden-variety Hashimoto's.

• Low TSH + high free T4/T3: hyperthyroidism or over-replacement. Heat intolerance is the thermal dashboard.

• Normal TSH + low-normal free T3 + rising rT3: conservation. Engines throttled. This is the pattern the single-TSH religion misses. Fix load, carbohydrate availability, sleep, and inflammation before you assume the gland is the problem.

• Normal everything + flat cold temperature curve + hypothyroid symptoms: possible conversion, receptor, or mitochondrial-readiness problem the venous draw cannot see. The curve is still data.

• After a sleepless night, morning TSH can be higher because sleep never applied the brake. Do not start a lifelong prescription on one post-call draw.

• Pregnancy needs trimester-aware ranges: TBG and totals up, first-trimester TSH often down because of hCG. Do not use non-pregnant cutoffs.

• On T4 replacement, TSH and free T4 tell you about supply to the pituitary. They do not guarantee peripheral T3. On T3-containing replacement, TSH is easily suppressed for hours after a dose; timing the draw is part of the measurement.

Reference intervals are population bells, not individual set-points. A TSH of 3.8 can be "in range" and still be a loud work order for that person. A free T3 at the bottom of the interval with a falling basal temperature is not a personality. Conventional practice is right that isolated rT3 and isolated free T3 should not be used to invent disease in a well person. The metabolic practice is right that a conservation pattern is information about engines, not a moral failing and not always a prescription for more hormone.

Read the conversation. Do not frame a single messenger.

Laboratory metrics as flux instruments

Labs are not diseases. They are probes of capacity, load, substrate choice, compensation, and tempo.

Thyroid tempo. TSH with clock-time and last night's sleep attached. Free T4 as reservoir. Free T3 as active tempo. rT3 and T3/rT3 as conversion versus inactivation. Interpret the wave, not the isolated morning TSH.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 31, 2026.

References

1. Weitzel JM, Iwen KA, 2011. Coordination of mitochondrial biogenesis by thyroid hormone. Molecular and Cellular Endocrinology 342(1-2):1-7. doi:10.1016/j.mce.2011.05.009
2. Bianco AC, McAninch EA, 2013. The role of thyroid hormone and brown adipose tissue in energy homoeostasis. Lancet Diabetes & Endocrinology 1(3):250-258. doi:10.1016/S2213-8587(13)70069-X
3. Flier JS, Harris M, Hollenberg AN, 2000. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. Journal of Clinical Investigation 105(7):859-861. doi:10.1172/JCI9725
4. Bianco AC, Salvatore D, Gereben B, et al., 2002. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 23(1):38-89. doi:10.1210/edrv.23.1.0455
5. Fliers E, Bianco AC, Langouche L, et al., 2015. Thyroid function in critically ill patients. Lancet Diabetes & Endocrinology 3(10):816-825. doi:10.1016/S2213-8587(15)00225-9
6. Rampy J, Torres-Manzo AP, Hoffsmith K, et al., 2026. Overnutrition in mice impairs thyroid hormone biosynthesis and utilization, causing hypothyroidism, despite remarkable thyroidal adaptations. Journal of Clinical Investigation 136(8). doi:10.1172/JCI194207
7. Ruhla S, Weickert MO, Arafat AM, et al., 2010. A high normal TSH is associated with the metabolic syndrome. Clinical Endocrinology 72(5):696-701. doi:10.1111/j.1365-2265.2009.03698.x
8. Chung GE, Kim D, Kim W, et al., 2012. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. Journal of Hepatology 57(1):150-156. doi:10.1016/j.jhep.2012.02.027
9. Park SY, Park SE, Jung SW, et al., 2017. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects. Clinical Endocrinology 87(1):87-96. doi:10.1111/cen.13345
10. Fontana L, Klein S, Holloszy JO, et al., 2006. Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. Journal of Clinical Endocrinology and Metabolism 91(8):3232-3235. doi:10.1210/jc.2006-0328
11. Iacovides S, Maloney SK, Bhana S, et al., 2022. Could the ketogenic diet induce a shift in thyroid function and support a metabolic advantage in healthy participants? A pilot randomized-controlled-crossover trial. PLoS One 17(6):e0269440. doi:10.1371/journal.pone.0269440
12. Virili C, Fallahi P, Antonelli A, et al., 2018. Gut microbiota and Hashimoto's thyroiditis. Reviews in Endocrine and Metabolic Disorders 19(4):293-300. doi:10.1007/s11154-018-9467-y
13. Sonnenburg ED, Smits SA, Tikhonov M, et al., 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529(7585):212-215. doi:10.1038/nature16504
14. Saravanan P, Chau WF, Roberts N, et al., 2002. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 57(5):577-585. doi:10.1046/j.1365-2265.2002.01654.x
15. Porter C, Reidy PT, Bhattarai N, et al., 2015. Resistance exercise training alters mitochondrial function in human skeletal muscle. Medicine & Science in Sports & Exercise 47(9):1922-1931. doi:10.1249/MSS.0000000000000605
16. Pietzner M, Uluvar B, Kolnes KJ, et al., 2024. Systemic proteome adaptions to 7-day complete caloric restriction in humans. Nature Metabolism 6(4):764-777. doi:10.1038/s42255-024-01008-9
17. Hamblin MR, 2018. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochemistry and Photobiology 94(2):199-212. doi:10.1111/php.12864

Related: Circadian Temperature · Circadian / Energy Phase · Fuel · Signals · Serotonin · Diabetes · Obesity · Immune · Cardiac · Aging · Methylene Blue · Philosophy of Medicine · GI · Reproductive

See the notice at the top of this page. Working hypothesis, not medical advice.